IMPLICAÇÕES DA OBRA DE MARCH E SIMON PARA AS TEORIAS DAS ORGANIZAÇÕES E TOMADA DE DECISÃO.

Autor: Ribeiro, Ivano¹ ivano.adm@gmail.com

Publikováno v: Revista Ibero-Americana de Estratégia (RIAE). Oct-Dec2015, Vol. 14 Issue 4, p149-159. 11p.

Mesure des risques de march\'e et de souscription vie en situation d'information incompl\'ete pour un portefeuille de pr\'evoyance

Autor: Jean-Paul F\'elix, Fr\'ed\'eric Planchet

In the framework of Embedded Value new standards, namely the MCEV norms, the latest principles published in June 2008 address the issue of market and underwriting risks measurement by using stochastic models of projection and valorization. Knowing th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______645::84228376806ef10596476bcd79710535
http://arxiv.org/pdf/1001.1908

A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.

Autor: Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy. massimiliano.bonifacio@univr.it., Scaffidi L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Miggiano MC; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Facchinelli D; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Tosoni L; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Pezone S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Griguolo D; Hematology Unit, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy., Ciotti G; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy., Danini M; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy., Bernardelli A; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Bresciani R; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Cavraro M; Department of Medicine, Oncology Unit, San Donà di Piave (VE), Italy., Crosera L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., De March E; Hematology Unit, San Martino Hospital, Belluno, Italy., Dell'Eva M; Hematology and Bone Marrow Transplant Unit, Ospedale Regionale San Maurizio, Bolzano, Italy., Dorotea L; Oncology Unit, Ospedali Riuniti Padova Sud-Schiavonia, Monselice (PD), Italy., Frison L; Hematology Unit, Ospedale Dell'Angelo, Mestre-Venezia, Italy., Furlani L; Oncology Unit, Ospedale Mater Salutis, Legnago (VR), Italy., Gianesello I; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Lovato E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Marchetti E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Morelli G; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Mullai R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Pizzano U; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Zoletto S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Fanin R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Krampera M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Trentin L; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Calistri E; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy., Carli G; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Binotto G; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Mar 26; Vol. 14 (1), pp. 53. Date of Electronic Publication: 2024 Mar 26.

Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients

Autor: Poullot, E., Zambello, R., Leblanc, F., Bareau, B., De March, E., Roussel, M., Boulland, M.L., Houot, R., Renault, A., Fest, T., Semenzato, G., Loughran, T., Lamy, T. ^*

Publikováno v: In Annals of Oncology October 2014 25(10):2030-2035

Chronic lymphoproliferative disorder of natural killer cells-related neurolymphomatosis with severe autonomic dysfunction: a case report.

Autor: Yamada, Kazuki¹ (AUTHOR) yamak354546@gmail.com, Inoue, Takashi² (AUTHOR), Nakamura, Shuntaro¹ (AUTHOR), Horiuchi, Kazuhiro¹ (AUTHOR), Tsutsumi, Yutaka³ (AUTHOR), Munakata, Satoru⁴ (AUTHOR), Yagi, Satoru⁵ (AUTHOR), Fukami, Yuki⁵ (AUTHOR), Katsuno, Masahisa^5,6 (AUTHOR), Yabe, Ichiro² (AUTHOR)

Publikováno v: BMC Neurology. 9/28/2024, Vol. 24 Issue 1, p1-7. 7p.